At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 41 enrolled
Drug / intervention
Myoinositolbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation
In Brief
A Phase 2 clinical trial evaluating Myoinositol for Myoinositol and 3 related conditions. Completed, enrolled 41 participants.
Detailed Summary
The objective of this study is to evaluate the effect of in-vitro myoinositol supplementation of human sperm on the outcome of cryopreservation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyoinositol, Cryopreservation, Human, Sperm
Countries--
CollaboratorsAjyal Hospital
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartAug 2016
Primary CompletionApr 2017
First PostedMay 2017
TodayJul 2026
First PostedMay 15, 2017
Enrollment StartAug 28, 2016
Primary CompletionApr 26, 2017
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.1 years ago
Interventions
Myoinositolbiological